-+ 0.00%
-+ 0.00%
-+ 0.00%

TEVA ANNOUNCES NEW OLANZAPINE LAI (TEV-'749) POST HOC DATA HIGHLIGHTING HIGH RATES OF STABILIZATION AND LONG-TERM EFFICACY AS ONCE-MONTHLY SUBCUTANEOUS INJECTABLE FOR THE TREATMENT OF SCHIZOPHRENIA IN ADULTS

路透·09/18/2026 20:30:00

登录查看新闻详情